沉默生物节律基因TIMELESS对卵巢癌SK-OV-3细胞免疫逃逸的抑制作用及其机制

doi:10.13481/j.1671-587X.20250310

Abstract

Abstract:

Objective To discuss the effect of circadion rhythm gene TIMELESS （TIM） silencing on immune escape of the ovarian cancer cells， and to clarify its related mechanism. Methods The CD8+T lymphocytes were isolated and identified by flow cytometry to detect the proportion of CD3+/CD8+ cell subsets. The human ovarian cancer SK-OV-3 cells were cultured in vitro and divided into interference plasmid transfected with TIM small interfering （siRNA）（si-TIM）， negative control plasmid （si-NC）， programmed death ligand 1 （PD-L1） over-expression plasmid （oe-PD-L1）， and negative control plasmid （oe-NC） groups. The cells were further divided into blank control group （BC group， non-transfection）， si-NC group （transfected with si-NC）， si-TIM group（transfected with si-TIM）， si-NC+oe-NC group （transfected with si-NC and oe-NC）， and si-TIM+oe-PD-L1 group （transfected with si-TIM and oe-PD-L1）. Real-time fluorescence quantitative PCR（RT-qPCR） and Western blotting methods were used to detect the expression levels of TIM mRNA and protein in the SK-OV-3 cells to verify TIM gene silencing. The transfected SK-OV-3 cells were co-cultured with activated CD8+T lymphocytes and divided into BC group （SK-OV-3 cells cultured alone）， BC/T group， si-NC/T group， si-TIM/T group， si-NC+oe-NC/T group， and si-TIM+oe-PD-L1/T group. CCK-8 method was used to detect the survival rates of the SK-OV-3 cells in various groups； flow cytometry was used to detect the apoptotic rates of the SK-OV-3 cells and positive expression rate of PD-L1 on surface of the cells in various groups； enzyme-linked immunosorbent assay （ELISA） method was used to detect the levels of interferon-γ （IFN-γ） and tumor necrosis factor-α （TNF-α） in the co-culture supernatant； lactate dehydrogenase （LDH） release assay was used to detect the cytotoxicity of the CD8+T lymphocytes in various groups； RT-qPCR method was used to detect the expression levels of TIM and PD-L1 mRNA in the SK-OV-3 cells in various groups； Western blotting method was used to detect the expression levels of TIM and PD-L1 proteins in the SK-OV-3 cells in various groups. Results After scparated with immune magnetic bead method， the proportion of CD8+T lymphocyte （CD3+/CD8+） subsets was （96.56%±0.59%）， indicating high purity of the extracted CD8+T lymphocytes. Compared with BC group， the expression levels of TIM mRNA and protein in the cells in si-TIM group were significantly decreased （P<0.01）， suggesting successful TIM gene silencing in the ovarian cancer SK-OV-3 cells. The CCK-8 results showed that compared with BC group， the survival rate of the SK-OV-3 cells in BC/T group was significantly decreased （P<0.01）； compared with BC/T group， the survival rate of the SK-OV-3 cells in si-TIM/T group was significantly decreased （P<0.01）. The flow cytometry results showed that compared with BC group， the apoptotic rate of the SK-OV-3 cells in BC/T group was significantly increased （P<0.01）； compared with BC/T group， the apoptotic rate of the SK-OV-3 cells in si-TIM/T group was significantly increased （P<0.01）； compared with si-TIM/T group， the apoptotic rate of the SK-OV-3 cells in si-TIM+oe-PD-L1/T group was significantly decreased （P<0.01）. Compared with BC group， the positive expression rate of PD-L1 on surface of the SK-OV-3 cells in si-TIM group was significantly decreased （P<0.01）. The ELISA results showed that compared with BC/T group， the levels of IFN-γ and TNF-α in the culture supernatant in si-TIM/T group were significantly increased （P<0.01）； compared with si-TIM/T group， the levels of IFN-γ and TNF-α in the supernatant in si-TIM+oe-PD-L1/T group were significantly decreased （P<0.01）. The LDH release assay results showed that compared with BC/T group， the cytotoxicity of the CD8+T lymphocytes in si-TIM/T group was significantly increased （P<0.01）； compared with si-TIM/T group， the cytotoxicity of the CD8+T lymphocytes in si-TIM+oe-PD-L1/T group was significantly weakened （P<0.01）. The RT-qPCR and Western blotting results showed that compared with BC group， the expression levels of PD-L1 mRNA and protein in the SK-OV-3 cells in si-TIM group were significantly decreased （P<0.01）； compared with si-TIM group， the expression level of PD-L1 protein in the cells in si-TIM+oe-PD-L1 group was significantly increased （P<0.01）. Conclusion TIM gene silencing enhances the cytotoxic effect of CD8+T lymphocytes on ovarian cancer SK-OV-3 cells and inhibits immune escape， and its mechanism may be related to the regulation of PD-L1 protein expression.

Key words: Ovarian cancer, Immune escape, TIMELESS gene, CD8+T lymphocytes, Programmed death ligand 1

CLC Number:

R737.31

Yuling GU,Cui ZHENG,Yunxian TANG. Inhibitory effect of silencing of circadian rhythm gene TIMELESS on immune escape of ovarian cancer SK-OV-3 cells and its mechanism[J].Journal of Jilin University(Medicine Edition), 2025, 51(3): 653-662.

Figures/Tables 9

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Tab. 1

Tab. 2

Fig. 6

Fig. 7

References 29

[1]	SONG J， SOKOLL L J， ZHANG Z， et al. VCAM-1 complements CA-125 in detecting recurrent ovarian cancer［J］. Clin Proteomics， 2023， 20（1）： 25.
[2]	LAMPROPOULOU D I， PAPADIMITRIOU M， PAPADIMITRIOU C， et al. The role of EMT-related lncRNAs in ovarian cancer［J］. Int J Mol Sci， 2023， 24（12）： 10079.
[3]	PREETAM S， MONDAL S， PRIYA S， et al. Targeting tumour markers in ovarian cancer treatment［J］. Clin Chim Acta， 2024， 559： 119687.
[4]	YIN S S， GAO F H. Molecular mechanism of tumor cell immune escape mediated by CD24/siglec-10［J］. Front Immunol， 2020， 11： 1324.
[5]	JIANG X J， WANG J， DENG X Y， et al. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape［J］. Mol Cancer， 2019， 18（1）： 10.
[6]	CAI Y D， CHIU J C. Timeless in animal circadian clocks and beyond［J］. FEBS J， 2022， 289（21）： 6559-6575.
[7]	VIPAT S， MOISEEVA T N. The TIMELESS roles in genome stability and beyond［J］. J Mol Biol， 2024， 436（1）： 168206.
[8]	COLANGELO T， CARBONE A， MAZZARELLI F， et al. Loss of circadian gene Timeless induces EMT and tumor progression in colorectal cancer via Zeb1-dependent mechanism［J］. Cell Death Differ， 2022， 29（8）： 1552-1568.
[9]	XING X， GU F， HUA L Y， et al. TIMELESS promotes tumor progression by enhancing macrophages recruitment in ovarian cancer［J］. Front Oncol， 2021， 11： 732058.
[10]	粟连秀，陈静平，杨达平，等. 沉默生物钟基因Timeless对卵巢癌SKOV3细胞凋亡和侵袭能力的影响［J］. 中国病理生理杂志， 2019， 35（7）： 1169-1175.
[11]	DONG X R， DAI H J， LIN Y P， et al. TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer［J］. J Transl Med， 2023， 21（1）： 400.
[12]	AKTAR N， CHEN Y T， ABBAS M， et al. Understanding of immune escape mechanisms and advances in cancer immunotherapy［J］. J Oncol， 2022， 2022： 8901326.
[13]	SAVID-FRONTERA C， VIANO M E， BAEZ N S， et al. Exploring the immunomodulatory role of virtual memory CD8+T cells： Role of IFN gamma in tumor growth control［J］. Front Immunol， 2022， 13： 971001.
[14]	GILES J R， GLOBIG A M， KAECH S M， et al. CD8+T cells in the cancer-immunity cycle［J］. Immunity， 2023， 56（10）： 2231-2253.
[15]	QIN Y Y， BAO X Y， ZHENG M Z. CD8+T-cell immunity orchestrated by iNKT cells［J］. Front Immunol， 2023， 13： 1109347.
[16]	WANG X M， ZHANG Y， ZHENG J， et al. LncRNA UCA1 attenuated the killing effect of cytotoxic CD8+T cells on anaplastic thyroid carcinoma via miR-148a/PD-L1 pathway［J］. Cancer Immunol Immunother， 2021， 70（8）： 2235-2245.
[17]	杨婷，郑锦秀，高书华，等. 钙连蛋白（CNX）通过促进MHCⅠ表达增强CD8+T细胞对结直肠癌细胞的杀伤作用［J］. 细胞与分子免疫学杂志， 2022， 38（2）： 97-102.
[18]	QIN R， ZHAO C， WANG C J， et al. Tryptophan potentiates CD8+T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation［J］. J Immunother Cancer， 2021， 9（7）： e002840.
[19]	CHANG W H， LAI A G. Timing gone awry： distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies［J］. J Transl Med， 2019， 17（1）： 132.
[20]	GAO Y Y， WU Y W， ZHANG N M， et al. IDH1 gene mutation activates Smad signaling molecules to regulate the expression levels of cell cycle and biological rhythm genes in human glioma U87-MG cells［J］. Mol Med Rep， 2021， 23（5）： 354.
[21]	YANG Y C， TANG X Z， LIN Z J， et al. An integrative evaluation of circadian gene TIMELESS as a pan-cancer immunological and predictive biomarker［J］. Eur J Med Res， 2023， 28（1）： 563.
[22]	ZHOU J H， ZHANG Y H， ZOU X W， et al. Aberrantly expressed timeless regulates cell proliferation and cisplatin efficacy in cervical cancer［J］. Hum Gene Ther， 2020， 31（5/6）： 385-395.
[23]	HOEKSTRA M E， VIJVER S V， SCHUMACHER T N. Modulation of the tumor micro-environment by CD8⁺ T cell-derived cytokines［J］. Curr Opin Immunol， 2021， 69： 65-71.
[24]	ZHU D， XU R D， HUANG X P， et al. Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1［J］. Cell Death Differ， 2021， 28（6）： 1773-1789.
[25]	CHA J H， YANG W H， XIA W Y， et al. Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1［J］. Mol Cell， 2018， 71（4）： 606-620.e7.
[26]	DUMITRU A， DOBRICA E C， CROITORU A， et al. Focus on PD-1/PD-L1 as a therapeutic target in ovarian cancer［J］. Int J Mol Sci， 2022， 23（20）： 12067.
[27]	CHARDIN L， LEARY A. Immunotherapy in ovarian cancer： thinking beyond PD-1/PD-L1［J］. Front Oncol， 2021， 11： 795547.
[28]	KHATOON E， PARAMA D， KUMAR A， et al. Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy［J］. Life Sci， 2022， 306： 120827.
[29]	CHEN J X， YI X J， GAO S X， et al. The possible regulatory effect of the PD-1/PD-L1 signaling pathway on Tregs in ovarian cancer［J］. Gen Physiol Biophys， 2020， 39（4）： 319-330.

Group	IFN-γ	TNF-α
BC/T	72.63±6.16	103.79±9.71
Si-NC/T	68.71±9.57	108.86±9.29
Si-TIM/T	133.32±9.91^*	202.29±14.00^*

Group	IFN-γ	TNF-α
BC/T	72.89±4.55	106.78±6.01
Si-NC+oe-NC/T	74.03±6.13	109.44±10.03
Si-TIM/T	134.83±11.28^*	209.53±9.59^*
Si-TIM+oe-PD-L1/T	92.57±4.25^△	153.55±8.23^△

Inhibitory effect of silencing of circadian rhythm gene TIMELESS on immune escape of ovarian cancer SK-OV-3 cells and its mechanism

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 9

References 29

Related Articles 6

Metrics

Comments

Recommended 0

[1]	Shuo ZHANG,Yunxiu XIA,Weiwei CHEN,Hongliang DONG,Bingjie CUI,Cuilan LIU,Zhiqiang LIU,Fei WANG,Jing DU. Effect of over-expression of NR2F2 on biological behaviors of human ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 58-67.
[2]	Qinghui WANG,Bo LI,Chuancui HU,Mingchao NIE,Xiaomei ZHENG. Effects of miR-107 on regulation of immune escape and taxol resistance of ovarian cancer cells [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 734-743.
[3]	LI Songyan, LIN Dongjing, YU Yang, LIU Shibing, XU Lu, SUN Qi, XU Ye. Effect of silencing sirtuin 3 on resveratrol-induced apoptosis of human ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(01): 45-49.
[4]	ZHANG Baoyue, ZHANG Junnong. Synergetic effect of epidermal growth factor receptor tyrosine kinase inhibitor kaempferol in combination with tarceva on apoptosis of ovarian cancer cells [J]. Journal of Jilin University Medicine Edition, 2016, 42(01): 31-35.
[5]	ZHAO Qiang, ZHOU Tong, ZHAI Ying-Xian, WANG Jian-Wei, JIN Zhao-Hui, SHI Ying-Ai. Expressions of MIF and VEGF in ovarian cancer tissues and their correlations with microvascular density  [J]. J4, 2010, 36(4): 713-716.
[6]	DONG Li-hua, LIU Feng, LI Yan-bo, FU Shi-b. Effects of recombinant plasmid pEgr-p53 transfected stably in combination with X-irradiation on cell cycle progression and proliferation in human SKOV-3 tumor cells in vitro [J]. J4, 2008, 34(3): 357-360.